Ranitidine Injection 50mg/2ml
-
Product is not available
Country Of Origin : India
Ranitidine Injection
Ranitidine Injection is a biocompatible injectable formulation for targeted H2 receptor antagonism, facilitating gastric acid suppression in acute clinical applications.
The 50mg/2ml volume provides a standardized dose, enabling precise administration and predictable therapeutic efficacy.
Key Features:
- Optimized aqueous injectable for rapid absorption
- 50mg active concentration per 2ml unit
- Physicochemical stability ensures reproducible clinical effect
- Regulated for professional institutional use
Attributes:
- 50mg/2ml for accurate dosing
- Injectable formulation with controlled flow characteristics
- Compliance with pharmaceutical quality standards
Composition and Formulation Details
Ranitidine Injection contains pharmaceutically pure Ranitidine Hydrochloride in sterile isotonic aqueous medium. Buffering agents maintain pH stability and prevent degradation, while excipients ensure solubility and homogeneity for reliable parenteral administration.
Functional Characteristics and Performance
The injection provides consistent bioavailability and rapid onset of action. Its optimized viscosity facilitates smooth intravenous or intramuscular administration with minimal discomfort. Stability under ambient and refrigerated conditions ensures predictable pharmacodynamics for professional clinical use.
Application and Industry Relevance
Ranitidine Injection is widely used in hospital pharmacies, emergency care units, and institutional procurement channels. Its bulk sourcing, OEM supply, and export-ready packaging align with regulated pharmaceutical markets, supporting professional B2B buyers seeking reliable acid-suppressive injectable therapy.
